Astrazeneca (AZN) Share-based Compensation (2011 - 2012)
Astrazeneca (AZN) posted Share-based Compensation of -$79.0 million for Q4 2012, down 113.51% on a QoQ basis from -$37.0 million in Q4 2011, and down 113.51% year-over-year from $584.6 million in Q1 2012.
Powered by 
Analysis
Astrazeneca (AZN) Share-based Compensation (2011 - 2012) Analysis & Trends
Astrazeneca has reported Share-based Compensation for 2 years, with the latest figure at -$79.0 million in Q4 2012.
- On a quarterly basis, Share-based Compensation fell 113.51% year-over-year to -$79.0 million in Q4 2012; TTM through Dec 2012 was -$419.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $719.0 million, up 8.94% from the prior year.
- Share-based Compensation was -$79.0 million for Q4 2012 at Astrazeneca, down from -$37.0 million in the prior quarter.
- The five-year high for Share-based Compensation was -$37.0 million in Q4 2011, with the low at -$79.0 million in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 659.69 Bn | 643.71 Bn | 5.90 Bn | - |
| 2 | General Electric | 337.12 Bn | 327.78 Bn | 6.95 Bn | - |
| 3 | Astrazeneca | 247.89 Bn | 242.60 Bn | 12.86 Bn | - |
| 4 | Citigroup | 236.49 Bn | -2,065.81 Bn | 24.75 Bn | - |
| 5 | Bhp | 220.99 Bn | 202.45 Bn | - | - |
| 6 | Rio Tinto | 206.31 Bn | 201.93 Bn | - | - |
| 7 | Diageo | 192.64 Bn | 190.61 Bn | - | - |
| 8 | National Grid | 165.59 Bn | 161.82 Bn | - | - |
| 9 | Unilever | 135.28 Bn | 128.25 Bn | - | - |
| 10 | Hdfc Bank | 119.43 Bn | 82.28 Bn | - | - |